Cargando…
Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis
Background: Short-term use of standard-dose proton pump inhibitors (PPIs) is the first-line initial non-eradication treatment for duodenal ulcer (DU), but the choice on individual PPI drug is still controversial. The purpose of this study is to compare the efficacy, safety, and cost-effectiveness of...
Autores principales: | Zhang, Jiaxing, Ge, Long, Hill, Matt, Liang, Yi, Xie, Juan, Cui, Dejun, Li, Xiaosi, Zheng, Wenyi, He, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330312/ https://www.ncbi.nlm.nih.gov/pubmed/30666204 http://dx.doi.org/10.3389/fphar.2018.01512 |
Ejemplares similares
-
Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis
por: Meng, Xiangbo, et al.
Publicado: (2023) -
Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple Helicobacter pylori eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers
por: Takeuchi, Toshihisa, et al.
Publicado: (2012) -
Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis
por: Morino, Yuko, et al.
Publicado: (2021) -
Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019
por: Zhang, Jiaxing, et al.
Publicado: (2020) -
Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials
por: Hu, Zhan-Hong, et al.
Publicado: (2017)